Precipio, Inc. Common Stock

PRPONASDAQ • USD
23.88 USD
↘ 0.13 (0.52%)🟢LIVE (AS OF 12:40 PM EDT)
🟢Market: OPEN

Shares of Precipio, Inc. Common Stock (PRPO) are trading at $23.88. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, PRPO appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 5, 2026.

Open?$24.03
High?$24.65
Low?$23.40
Prev. Close?$24.00
Volume?12.7K
Avg. Volume?131.2K
VWAP?$24.07
Rel. Volume?0.10x
Bid / Ask
Bid?$20.29 × 100
Ask?$27.65 × 100
Spread?$7.36
Midpoint?$23.97
Valuation & Ratios
Market Cap?43.0M
Shares Out?1.8M
Float?1.6M
Float %?92.0%
P/E Ratio?N/A
P/B Ratio?2.91
EPS?-$0.68
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Employees
71
Market Cap
43.0M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
2000-07-18
Address
4 SCIENCE PARK
NEW HAVEN, CT 06511
Phone: 203 787 7888
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
75
Short Sent.?
51
Piotroski F-Score?3/9Weak
Altman Z-Score?-1.71Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?4.49%Low
Short Interest?73.8K
Days to Cover?1.0
Free Float1.6M
Avg Daily Volume191.5K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.77Adequate
Quick Ratio?1.56Adequate
Cash Ratio?0.83Adequate
Debt/Equity?0.08Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
87/100
P/E?
N/A▾
P/B?
Peers
100
S&P
57
2.91CHEAP▾
P/S?
Peers
100
S&P
77
1.55CHEAP▾
P/FCF?
Peers
100
S&P
9
54.5PRICEY▾
EV/EBITDA?
S&P
97
-114.1CHEAP▾
EV/Sales?
Peers
100
S&P
84
1.48CHEAP▾
Returns & Efficiency
ROE?
S&P
10
-8.2%WEAK▾
ROA?
S&P
3
-5.7%WEAK▾
Cash Flow & Enterprise
FCF?$789.0K
Enterprise Value?$41.1M
Fundamentals ratios updated end of day